Dr. Alida F. Griffith, MD
Neurology (Neurology Physician)
12039 Ne 128th St, Suite 300
Kirkland, WA 98034
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Massachusetts Medical School (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 189
Licensed in Washington since 2003, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of Massachusetts Medical School
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
WA license MD00042474 (first issued 2003; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Swedish Edmonds Hospital Edmonds, WA
- Evergreenhealth Medical Center Kirkland, WA
- Evergreenhealth Monroe Monroe, WA
Medical groups
- Select Rehabilitation, LLC (2,046 clinicians)
- Select Outpatient Services Inc (805 clinicians)
- King County Public Hospital District No 2 (608 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 189
- Services billed
- 979
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 412 | 160 |
| Established patient office or other outpatient visit, 40-54 minutes | 61 | 44 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 36 | 13 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 36 | 12 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Kirkland, WA | 652 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Kirkland, WA | 547 |
| Rytary (carbidopa/levodopa) Other prescribers in Kirkland, WA | 231 |
| Donepezil Hcl Other prescribers in Kirkland, WA | 147 |
| Gabapentin Other prescribers in Kirkland, WA | 138 |
| Pramipexole Dihydrochloride (pramipexole di-hcl) Other prescribers in Kirkland, WA | 133 |
| Rasagiline Mesylate | 120 |
| Entacapone | 120 |
| Amantadine (amantadine hcl) Other prescribers in Kirkland, WA | 107 |
| Escitalopram Oxalate Other prescribers in Kirkland, WA | 104 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 21 payments worth $535 in total to this clinician.
| Janssen Biotech, Inc. | $120 |
|---|---|
| Merz Pharmaceuticals, LLC | $81.45 |
| AbbVie Inc. | $56.66 |
| Boston Scientific Corporation | $44.95 |
| Abbott Laboratories | $43.16 |
| Csl Behring | $42.95 |
| Alnylam Pharmaceuticals Inc. | $29.71 |
| Novartis Pharmaceuticals Corporation | $25.06 |
| Food and Beverage | $535 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $57,916 in research payments for these studies, mostly to the institutions running them.
- A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease
UCB SA · Completed · NCT04658186 - An Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's Disease
UCB SA · Terminated · NCT05543252
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.